MidFirst Bank’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24K Hold
13
﹤0.01% 770
2026
Q1
$1.25K Hold
13
﹤0.01% 735
2025
Q4
$1.26K Buy
+13
New +$1.11K ﹤0.01% 696

Other funds holding IRMD

MidFirst Bank's IRMD Position: Q2 2026 in Review

MidFirst Bank held its iRadimed (IRMD) position steady in Q2 2026 at 13 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #770.

MidFirst Bank first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.26K in Q4 2025. 159 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • MidFirst Bank held 13 shares of iRadimed worth $1.24K as of Q2 2026.
  • MidFirst Bank left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #770 holding.
  • MidFirst Bank first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • MidFirst Bank's iRadimed position peaked at $1.26K in Q4 2025.
  • 159 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.